Schuetz Thomas J. (CIK 1591464) reported 6 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-02-10). Recent activity: Sell CMPX (36,687 shares), Sell CMPX (46,777 shares), Buy CMPX (250,000 shares), Sell CMPX (44,025 shares), Buy CMPX (10,000 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-02-10 | Compass Therapeutics, Inc. (CMPX) | CHIEF EXECUTIVE OFFICER | Sell | 36,687 | $239,199 |
| 2026-01-12 | Compass Therapeutics, Inc. (CMPX) | CHIEF EXECUTIVE OFFICER | Sell | 46,777 | $250,257 |
| 2026-01-05 | Compass Therapeutics, Inc. (CMPX) | CEO | Buy | 250,000 | $1.3M |
| 2025-11-18 | Compass Therapeutics, Inc. (CMPX) | CHIEF EXECUTIVE OFFICER | Sell | 44,025 | $212,641 |
| 2025-05-27 | Compass Therapeutics, Inc. (CMPX) | CHIEF EXECUTIVE OFFICER | Buy | 10,000 | $21,100 |
| 2025-02-11 | Compass Therapeutics, Inc. (CMPX) | CEO | Sell | 41,687 | $145,904 |
Source: SEC Form 4 filings · as of 2026-02-10